Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.66 |
| ▸ | TK2 | O00142 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21158662 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL5981723 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL21114095 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL5981728 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL22607139 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL21158663 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL22641566 | 1.00 | TK1 (0.70) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL9780661 | 0.89 | TK1 (0.69) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL5983020 | 0.89 | TK1 (0.69) | TK1LMNASMN1; SMN2ALOX12ADRA1A | |
| SCHEMBL15285228 | 0.89 | TK1 (0.69) | TK1LMNASMN1; SMN2ALOX12ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025024123-A1 | NOVEL CITICOLINE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-30 | — | — | WO | claimed |
| EP-3736568-B1 | DETECTION METHOD FOR ANALOG DERIVED FROM TRIFLURIDINE | TAIHO PHARMACEUTICAL CO LTD (JP) | 2024-09-18 | — | — | EP | claimed |
| CN-116916936-A | Compositions and methods for delivering RNA | 再生技术有限责任公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116286830-A | Aptamer | 中国人民解放军军事科学院军事医学研究院 | 2023-06-23 | — | — | CN | claimed |
| CN-115151263-A | Aptamers and uses thereof | 爱普济德生物技术有限公司 | 2022-10-04 | — | — | CN | claimed |
| EP-3736568-A1 | DETECTION METHOD FOR ANALOG DERIVED FROM TRIFLURIDINE | Taiho Pharmaceutical Co., Ltd. (JP) | 2020-11-11 | — | — | EP | claimed |
| US-10816517-B2 | Method for detecting trifluridine-related substance by high-performance liquid chromatography | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-10-27 | — | — | US | claimed |
| US-20190212309-A1 | METHOD FOR DETECTING TRIFLURIDINE-RELATED SUBSTANCE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2019-07-11 | — | — | US | claimed |
| EP-4665405-A1 | DNA COMPOSITIONS COMPRISING MODIFIED URACIL | Flagship Pioneering Innovations VII, LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4580609-A2 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | Rejuvenation Technologies Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| CN-113785062-B | Aptamer and use thereof | 爱普济德生物技术有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119789852-A | Compositions and methods for delivering RNA | 再生技术有限责任公司 | 2025-04-08 | — | — | CN | disclosed |
| WO-2025049632-A1 | COMPOSITIONS AND METHODS FOR BROAD DELIVERY OF RNA TO TISSUE | REJUVENATION TECHNOLOGIES INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| CN-119552875-A | Aptamer and use thereof | 爱普济德生物技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| EP-3519571-B1 | COMPOSITIONS, METHODS AND SYSTEMS FOR IDENTIFYING CANDIDATE NUCLEIC ACID AGENT | APTITUDE MEDICAL SYSTEMS INC (US) | 2022-07-27 | — | — | EP | disclosed |
| CN-107236011-B | Nucleoside compound or salt thereof, nucleic acid and application thereof | 中国人民解放军军事医学科学院毒物药物研究所 | 2020-11-27 | — | — | CN | disclosed |
| EP-3736568-A1 | DETECTION METHOD FOR ANALOG DERIVED FROM TRIFLURIDINE | Taiho Pharmaceutical Co., Ltd. (JP) | 2020-11-11 | — | — | EP | disclosed |
| US-10816517-B2 | Method for detecting trifluridine-related substance by high-performance liquid chromatography | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-10-27 | — | — | US | disclosed |
| US-10809237-B2 | Method for detecting trifluridine-related substance by high-performance liquid chromatography | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2020-10-20 | — | — | US | disclosed |
| US-20190212309-A1 | METHOD FOR DETECTING TRIFLURIDINE-RELATED SUBSTANCE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2019-07-11 | — | — | US | disclosed |